Almotriptan is prescribed to treat the acute headache phase of migraine attacks with or without aura. It is a triptan drug discovered and developed by Almirall for the treatment of heavy migraine headache. Reference standards of Almotriptan API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Almotriptan
Catalogue No.:PA 28 84000
CAS :
Molecular Formula : C17H25N3O2S
Molecular Weight : 335.40
Almotriptan-d6 Hydrochloride
Catalogue No.:PA STI 004830
Molecular Formula : C17H20D6ClN3O2S
Molecular Weight : 377.96
N-Desmethyl Almotriptan-d3
Catalogue No.:PA STI 027990
Molecular Formula : C16H20D3N3O2S
Molecular Weight : 324.46
Didesmethyl Almotriptan-d4
Catalogue No.:PA STI 030890
Molecular Formula : C15H17D4N3O2S
Molecular Weight : 311.44
Almotriptan Related Compound A ({3-[2-(Dimethylamino)ethyl]-5-[(pyrrolidine-1-yl)sulfonylmethyl]-1H (1013523)
Catalogue No.:PA USP1013523
Molecular Formula : NA
Molecular Weight : NA
Almotriptan Related Compound B (2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine hem (1013545)
Catalogue No.:PA USP1013545
Almotriptan Malate (1013512)
Catalogue No.:PA USP1013512
Almotriptan Related Compound C (N-methyl-2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethan (1013556)
Catalogue No.:PA USP1013556
Almotriptan System Suitability (Mixture of Almotriptan Malate and Almotriptan Monomethyl Analog) (1013534)
Catalogue No.:PA USP1013534
Almotriptan Related Compound D (1-[({3-[2-(dimethylamino)ethyl]indol-5-yl}methyl)sulfonyl]pyrrolidi (1013567)
Catalogue No.:PA USP1013567
1-((4-Aminobenzenemethane)sulfonyl)pyrrolidine
Catalogue No.:PA 28 84530
Molecular Formula : C11H16N2O2S
Molecular Weight : 240.32
N-Methyl-N-(2-(1-nitroso-5-((pyrrolidin-1-ylsulfonyl)methyl)-1H-indol-3-yl)ethyl)nitrous Amide
Catalogue No.:PA 28 0841000
Molecular Formula : C16H21N5O4S
Molecular Weight : 379.44
Spiroalmotriptan
Catalogue No.:PA 28 0841001
Molecular Formula : C17H25N3O3S
Molecular Weight : 351.47
2-Hydroxyalmotriptan
Catalogue No.:PA 28 0841002
Almotriptan System Suitability (Mixture of Almotriptan Malate and Almotriptan Monomethyl Analog)
Catalogue No.:PA 28 0841003
1-[({3-[2-(dimethylamino)ethyl]indol-5-yl}methyl)sulfonyl]pyrrolidine N-oxide hydrochloride
Catalogue No.:PA 28 0841004
Molecular Formula : C17H26ClN3O3S
Molecular Weight : 387.92
Almotriptan N-dimer
Catalogue No.:PA 28 0841005
Molecular Formula : C30H41N5O2S
Molecular Weight : 535.75
N,N-Dimethyl-2-(1-nitroso-5-((pyrrolidin-1-ylsulfonyl)methyl)-1H-indol-3-yl)ethan-1-amine
Catalogue No.:PA 28 0841006
Molecular Formula : C17H24N4O3S
Molecular Weight : 364.46
N-Methyl-N-(2-(5-((pyrrolidin-1-ylsulfonyl)methyl)-1H-indol-3-yl)ethyl)nitrous Amide
Catalogue No.:PA 28 0841007
Molecular Formula : C16H22N4O3S
Molecular Weight : 350.44
N-Nitroso Spiro Almotriptan
Catalogue No.:PA 28 0841008
Molecular Formula : C17H24N4O4S
Molecular Weight : 380.46
N-Methyl-N-(2-(1-nitroso-5-((pyrrolidin-1-ylsulfonyl)methyl)-1H-indol-3-yl)ethyl)propan-2-amine
Catalogue No.:PA 28 0841009
Molecular Formula : C19H28N4O3S
Molecular Weight : 392.52
2-(1-Nitroso-5-((pyrrolidin-1-ylsulfonyl)methyl)-1H-indol-3-yl)ethan-1-amine
Catalogue No.:PA 28 0841010
Molecular Formula : C15H20N4O3S
Molecular Weight : 336.41
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
